Cargando…

PET/CT variants and pitfalls in malignant melanoma

(18)F-FDG PET/CT plays an increasingly pivotal role in the staging and post-treatment monitoring of high-risk melanoma patients, augmented by the introduction of therapies, including tyrosine kinase inhibitors (TKI) and immune checkpoint inhibitors (ICIs), that have novel modes of action that challe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aide, Nicolas, Iravani, Amir, Prigent, Kevin, Kottler, Diane, Alipour, Ramin, Hicks, Rodney J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724662/ https://www.ncbi.nlm.nih.gov/pubmed/34983677 http://dx.doi.org/10.1186/s40644-021-00440-4

Ejemplares similares

The utility of pharmacological and radiological interventions to optimize diagnostic information from PET/CT
por: Dudoignon, David, et al.
Publicado: (2020)

(18)F-FDG PET/CT versus Diagnostic Contrast-Enhanced CT for Follow-Up of Stage IV Melanoma Patients Treated by Immune Checkpoint Inhibitors: Frequency and Management of Discordances over a 3-Year Period in a University Hospital
por: Le Goubey, Jean-Baptiste, et al.
Publicado: (2021)

FDG PET/CT for assessing tumour response to immunotherapy: Report on the EANM symposium on immune modulation and recent review of the literature
por: Aide, Nicolas, et al.
Publicado: (2018)

FDG-PET/CT pitfalls in oncological head and neck imaging
por: Purohit, Bela S., et al.
Publicado: (2014)

Intra-patient comparison of physiologic (68)Ga-PSMA-11 and (18)F-DCFPyL PET/CT uptake in ganglia in prostate cancer patients: a pictorial essay
por: Osman, Medhat M., et al.
Publicado: (2021)

(18)F-FDG PET/CT based spleen to liver ratio associates with clinical outcome to ipilimumab in patients with metastatic melanoma
por: Wong, Annie, et al.
Publicado: (2020)

CT, MRI and PET imaging in peritoneal malignancy
por: Patel, Chirag M., et al.
Publicado: (2011)

(68)Ga PSMA-11 PET with CT urography protocol in the initial staging and biochemical relapse of prostate cancer
por: Iravani, Amir, et al.
Publicado: (2017)

How We Read Oncologic FDG PET/CT
por: Hofman, Michael S., et al.
Publicado: (2016)

The motivations and methodology for high-throughput PET imaging of small animals in cancer research
por: Aide, Nicolas, et al.
Publicado: (2012)

So, you want to get into “total-body” PET/CT scanning? An installation guide for beginners!
por: Hicks, Rodney J.
Publicado: (2023)

PET/CT‐Detected myofibroblastoma of the breast with bizarre cells: A potential diagnostic pitfall of malignancy
por: Angelico, Giuseppe, et al.
Publicado: (2021)

Pitfalls and artifacts in the interpretation of oncologic PET/CT of the chest
por: Meirelles, Gustavo de Souza Portes, et al.
Publicado: (2017)

Musculoskeletal pitfalls in (68)Ga-PSMA PET/CT
por: Pontes, Írline Cordeiro de Macedo, et al.
Publicado: (2023)

Gallium-68 Ventilation/Perfusion PET-CT and CT Pulmonary Angiography for Pulmonary Embolism Diagnosis: An Interobserver Agreement Study
por: Le Pennec, Romain, et al.
Publicado: (2021)

Injectable facial fillers: imaging features, complications, and diagnostic pitfalls at MRI and PET CT
por: Mundada, Pravin, et al.
Publicado: (2017)

Colonic Malignant Melanoma: (18)F-FDG PET/CT Findings
por: Kaya, Eser, et al.
Publicado: (2018)

FDG-PET/CT pitfalls in gynecological and genitourinary oncological imaging
por: Lakhani, A, et al.
Publicado: (2015)

The clinical significance and management of lesion motion due to respiration during PET/CT scanning
por: Callahan, Jason, et al.
Publicado: (2011)

PET/CT in paediatric malignancies - An update
por: Padma, Subramanyam, et al.
Publicado: (2016)

The role of (18)F-FDG-PET/CT in evaluating retroperitoneal masses -Keeping your eye on the ball!
por: Hung, Te-Jui, et al.
Publicado: (2019)

Malignant Melanoma
por: Perera, Eshini, et al.
Publicado: (2013)

PET/CT: will it change the way that we use CT in cancer imaging?
por: Hicks, Rodney J, et al.
Publicado: (2006)

Prevalence and malignancy risk of focal colorectal incidental uptake detected by (18)F-FDG-PET or PET/CT: a meta-analysis
por: Treglia, Giorgio, et al.
Publicado: (2014)

PET/CT Findings of a Patient with Cardiac Metastasis of Subungual Malign Melanoma
por: Ekmekçioğlu, Özgül, et al.
Publicado: (2019)

Malignancy Rate of Indeterminate Findings on FDG-PET/CT in Cutaneous Melanoma Patients
por: Kudura, Ken, et al.
Publicado: (2021)

Cardiac Metastasis of Malignant Melanoma Detected by (18)F-FDG PET/CT
por: Zhang, Hongzhe, et al.
Publicado: (2023)

Molecular imaging phenotyping for selecting and monitoring radioligand therapy of neuroendocrine neoplasms
por: Iravani, Amir, et al.
Publicado: (2022)

What Does This Mutation Mean? The Tools and Pitfalls of Variant Interpretation in Lymphoid Malignancies
por: Guillermin, Yann, et al.
Publicado: (2018)

CT and PET/CT findings of primary pulmonary malignant melanoma: a case report and literature review
por: Chen, Yanling, et al.
Publicado: (2023)

(18)F-fluorodeoxyglucose PET/CT findings in a systemic inflammatory response syndrome after COVID-19 vaccine
por: Steinberg, Julie, et al.
Publicado: (2021)

The Role and Potential of (18)F-FDG PET/CT in Malignant Melanoma: Prognostication, Monitoring Response to Targeted and Immunotherapy, and Radiomics
por: Filippi, Luca, et al.
Publicado: (2022)

Comparison of (18)F-FDG PET/CT and ultrasound in staging of patients with malignant melanoma
por: Weber, Philipp, et al.
Publicado: (2022)

Pitfalls in Gallium-68 PSMA PET/CT Interpretation—A Pictorial Review
por: Shetty, Deepa, et al.
Publicado: (2018)

Perspectives on joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards for [(18)F]FDG PET/CT imaging during immunomodulatory treatments in patients with solid tumors
por: Lopci, E., et al.
Publicado: (2022)

Sinonasal malignant melanoma with diffuse carcinomatosis: initial PET/CT staging and follow-up CT/MR imaging
por: Nguyen, Ba D.
Publicado: (2015)

Conspicuity of Malignant Lesions on PET/CT and Simultaneous Time-Of-Flight PET/MRI
por: Minamimoto, Ryogo, et al.
Publicado: (2017)

CT colonography: avoiding traps and pitfalls
por: Lefere, Philippe, et al.
Publicado: (2011)

The Superiority of Fibroblast Activation Protein Inhibitor (FAPI) PET/CT Versus FDG PET/CT in the Diagnosis of Various Malignancies
por: Dong, Yanzhao, et al.
Publicado: (2023)

PET-CT in Clinical Adult Oncology: III. Gastrointestinal Malignancies
por: Koppula, Bhasker R., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_eglulf2coo31cgj74a6gnatqi9